Search results
Results from the WOW.Com Content Network
Thoratec was incorporated in California in 1976 as Thoratec Laboratories Corporation. It completed its initial public offering (IPO) of stock in 1981, trading under the ticker "THOR". [5] [6] The company's efforts were focused on developing devices for circulatory support and vascular graft applications. [5]
Thoratec (NAS: THOR) reported earnings on Feb. 5. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 29 (Q4), Thoratec beat expectations on revenues and met ...
Thoratec (NAS: THOR) is expected to report Q1 earnings on May 2. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average ...
The 10-second takeawayFor the quarter ended March 31 (Q1), Thoratec beat expectations on revenues and crushed expectations on earnings per share. Compared Thoratec Crushes Earnings Estimates
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
Thoratec (NAS: THOR) reported earnings on Nov. 1. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Sep. 29 (Q3), Thoratec beat expectations on revenues and beat ...
The 10-second takeawayFor the quarter ended Dec. 31 (Q4), Thoratec beat slightly on revenues and beat expectations on earnings per share. Compared to the Thoratec Beats Up on Analysts Yet Again
What: Shares of Thoratec (NAS: THOR) , whose devices. Skip to main content. Finance. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join ...